CQDM is organized according to a unique public-private partnership model. CQDM was funded in 2008 by 3 pharmaceutical companies and 3 public institutions to support innovative research activities, primarily of a precompetitive nature, where the needs of the pharmaceutical industry are at the focus of the research agenda.